Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Other Non-Current Assets (2021 - 2025)

Historic Other Non-Current Assets for LifeStance Health (LFST) over the last 5 years, with Q3 2025 value amounting to $6.1 million.

  • LifeStance Health's Other Non-Current Assets fell 1752.09% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.1 million, marking a year-over-year decrease of 1752.09%. This contributed to the annual value of $7.7 million for FY2024, which is 2910.51% down from last year.
  • Latest data reveals that LifeStance Health reported Other Non-Current Assets of $6.1 million as of Q3 2025, which was down 1752.09% from $6.9 million recorded in Q2 2025.
  • LifeStance Health's Other Non-Current Assets' 5-year high stood at $13.0 million during Q3 2023, with a 5-year trough of $3.3 million in Q2 2021.
  • For the 5-year period, LifeStance Health's Other Non-Current Assets averaged around $8.2 million, with its median value being $7.8 million (2022).
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first soared by 23695.4% in 2022, then tumbled by 4307.0% in 2024.
  • Over the past 5 years, LifeStance Health's Other Non-Current Assets (Quarter) stood at $3.4 million in 2021, then soared by 213.08% to $10.8 million in 2022, then increased by 0.93% to $10.9 million in 2023, then dropped by 29.11% to $7.7 million in 2024, then fell by 20.83% to $6.1 million in 2025.
  • Its last three reported values are $6.1 million in Q3 2025, $6.9 million for Q2 2025, and $7.6 million during Q1 2025.